Dr. Ajay Singh, MD

NPI: 1184807786
Total Payments
$74,065
2024 Payments
$15,435
Companies
24
Transactions
123
Medicare Patients
10,444
Medicare Billing
$8.7M

Payment Breakdown by Category

Other$59,496 (80.3%)
Travel$8,683 (11.7%)
Food & Beverage$5,886 (7.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $56,950 20 76.9%
Travel and Lodging $8,683 14 11.7%
Food and Beverage $5,886 78 7.9%
Honoraria $2,077 3 2.8%
Entertainment $454.36 7 0.6%
Debt forgiveness $14.59 1 0.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $37,801 25 $0 (2024)
Allergan, Inc. $28,681 33 $0 (2022)
Alimera Sciences, Inc. $3,642 18 $0 (2024)
Beaver-Visitec International, Inc. $1,000 1 $0 (2018)
Genentech USA, Inc. $617.83 11 $0 (2024)
OPTOS, INC. $603.89 9 $0 (2018)
Regeneron Healthcare Solutions, Inc. $363.75 3 $0 (2024)
Apellis Pharmaceuticals, Inc. $231.21 3 $0 (2022)
Novartis Pharmaceuticals Corporation $198.48 2 $0 (2019)
Astellas Pharma US Inc $148.91 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $15,435 15 ABBVIE INC. ($14,873)
2023 $13,754 21 AbbVie Inc. ($12,736)
2022 $13,324 21 ABBVIE INC. ($10,192)
2021 $770.16 5 Allergan, Inc. ($510.29)
2020 $10,900 17 Allergan, Inc. ($8,793)
2019 $3,692 12 Allergan Inc. ($3,035)
2018 $15,367 17 Allergan Inc. ($14,123)
2017 $823.02 15 Optos, Inc. ($454.36)

All Payment Transactions

123 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
10/28/2024 Genentech USA, Inc. Vabysmo (Drug) Food and Beverage In-kind items and services $91.28 General
Category: Immunology and Ophthalmology
09/23/2024 ABBVIE INC. OZURDEX (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,950.00 General
Category: EYE CARE
09/05/2024 ABBVIE INC. OZURDEX (Drug) Travel and Lodging In-kind items and services $1,567.46 General
Category: EYE CARE
09/05/2024 ABBVIE INC. OZURDEX (Drug) Food and Beverage In-kind items and services $119.13 General
Category: EYE CARE
08/29/2024 Genentech USA, Inc. Susvimo (Drug), Vabysmo Food and Beverage In-kind items and services $24.46 General
Category: Immunology and Ophthalmology
08/22/2024 Alimera Sciences, Inc. YUTIQ (Drug), ILUVIEN Food and Beverage In-kind items and services $161.00 General
Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye
07/17/2024 ABBVIE INC. OZURDEX (Drug) Food and Beverage In-kind items and services $36.77 General
Category: EYE CARE
07/12/2024 Alimera Sciences, Inc. YUTIQ (Drug), ILUVIEN Food and Beverage In-kind items and services $24.24 General
Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye
06/21/2024 ABBVIE INC. OZURDEX (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,950.00 General
Category: EYE CARE
05/31/2024 Alimera Sciences, Inc. YUTIQ (Drug), ILUVIEN Food and Beverage In-kind items and services $15.24 General
Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye
05/30/2024 ABBVIE INC. OZURDEX (Drug) Travel and Lodging In-kind items and services $1,128.75 General
Category: EYE CARE
05/30/2024 ABBVIE INC. OZURDEX (Drug) Food and Beverage In-kind items and services $121.13 General
Category: EYE CARE
05/08/2024 Alcon Vision LLC Constellation (Device) Food and Beverage In-kind items and services $23.52 General
Category: Ophthalmology
04/17/2024 Regeneron Healthcare Solutions, Inc. EYLEA HD (Biological) Food and Beverage In-kind items and services $128.28 General
Category: OPHTHALMOLOGY
04/17/2024 Alimera Sciences, Inc. ILUVIEN (Drug), YUTIQ Food and Beverage In-kind items and services $94.00 General
Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid
12/19/2023 AbbVie Inc. OZURDEX (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,950.00 General
Category: EYE CARE
12/19/2023 AbbVie Inc. OZURDEX (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,250.00 General
Category: EYE CARE
12/12/2023 AbbVie Inc. OZURDEX (Drug) Travel and Lodging In-kind items and services $1,591.20 General
Category: EYE CARE
12/12/2023 AbbVie Inc. OZURDEX (Drug) Travel and Lodging In-kind items and services $531.80 General
Category: EYE CARE
12/12/2023 AbbVie Inc. OZURDEX (Drug) Travel and Lodging In-kind items and services $237.48 General
Category: EYE CARE
12/12/2023 AbbVie Inc. OZURDEX (Drug) Food and Beverage In-kind items and services $85.62 General
Category: EYE CARE
12/12/2023 AbbVie Inc. OZURDEX (Drug) Food and Beverage In-kind items and services $29.09 General
Category: EYE CARE
12/12/2023 AbbVie Inc. OZURDEX (Drug) Food and Beverage In-kind items and services $24.88 General
Category: EYE CARE
12/12/2023 AbbVie Inc. OZURDEX (Drug) Food and Beverage In-kind items and services $19.69 General
Category: EYE CARE
11/14/2023 Alimera Sciences, Inc. ILUVIEN (Drug) Food and Beverage Cash or cash equivalent $94.00 General
Category: OPHTHALMOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 2,659 28,411 $4.8M $2.4M
2022 18 2,325 8,899 $3.9M $2.0M
2021 22 2,833 11,713 $4.3M $2.3M
2020 21 2,627 10,983 $3.7M $1.9M
Total Patients
10,444
Total Services
60,006
Medicare Billing
$8.7M
Procedure Codes
80

All Medicare Procedures & Services

80 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0178 Injection, aflibercept, 1 mg Office 2023 158 1,816 $2.3M $1.2M 55.1%
J2777 Injection, faricimab-svoa, 0.1 mg Office 2023 63 19,740 $1.1M $570,082 52.0%
J2778 Injection, ranibizumab, 0.1 mg Office 2023 41 830 $380,380 $150,126 39.5%
67028 Injection of drug into eye Office 2023 303 1,635 $475,200 $145,106 30.5%
92014 Established patient complete exam of visual system Office 2023 682 1,151 $198,568 $100,643 50.7%
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg Office 2023 31 371 $97,634 $58,669 60.1%
92134 Imaging of retina Office 2023 642 1,821 $101,717 $53,030 52.1%
J3590 Unclassified biologics Office 2023 101 357 $42,840 $17,684 41.3%
92242 Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye Office 2023 81 81 $26,568 $16,144 60.8%
67041 Removal of membrane of retina Facility 2023 12 12 $22,178 $10,631 47.9%
92235 Exam of retinal blood vessels using a special camera after injection of a dye Office 2023 102 105 $16,470 $10,587 64.3%
92012 Established patient problem focused exam of visual system Office 2023 74 105 $13,170 $6,905 52.4%
67210 Destruction of growth of retina using a laser Office 2023 12 15 $14,928 $5,938 39.8%
92250 Photography of the retina Office 2023 120 123 $10,428 $3,106 29.8%
67145 Photocoagulation treatment to prevent detachment of retina Office 2023 16 17 $11,730 $3,099 26.4%
92004 New patient complete exam of visual system Office 2023 28 28 $6,058 $2,633 43.5%
92202 Extended exam of the back part of the eye with optic nerve drawing Office 2023 145 145 $3,748 $1,610 43.0%
J9035 Injection, bevacizumab, 10 mg Office 2023 17 28 $2,520 $1,535 60.9%
92201 Extended exam of the back part of the eye with retinal drawing Office 2023 31 31 $1,114 $583.75 52.4%
J0178 Injection, aflibercept, 1 mg Office 2022 134 1,748 $2.2M $1.2M 56.5%
J2778 Injection, ranibizumab, 0.1 mg Office 2022 48 1,439 $665,742 $314,640 47.3%
67028 Injection of drug into eye Office 2022 251 1,566 $442,750 $140,552 31.7%
92014 Established patient complete exam of visual system Office 2022 611 1,097 $183,199 $93,618 51.1%
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg Office 2022 37 371 $99,109 $58,346 58.9%
J3590 Unclassified biologics Office 2022 94 418 $107,400 $53,137 49.5%

About Dr. Ajay Singh, MD

Dr. Ajay Singh, MD is a Specialist healthcare provider based in Independence, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1184807786.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ajay Singh, MD has received a total of $74,065 in payments from pharmaceutical and medical device companies, with $15,435 received in 2024. These payments were reported across 123 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($56,950).

As a Medicare-enrolled provider, Singh has provided services to 10,444 Medicare beneficiaries, totaling 60,006 services with total Medicare billing of $8.7M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Retina Specialist, Ophthalmology
  • Location Independence, MO
  • Active Since 12/06/2007
  • Last Updated 03/11/2022
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1184807786

Products in Payments

  • OZURDEX (Drug) $66,482
  • ILUVIEN (Drug) $3,232
  • California (Device) $454.36
  • EYLEA (Biological) $353.65
  • Vabysmo (Drug) $240.10
  • YUTIQ (Drug) $213.32
  • VABYSMO (Drug) $166.72
  • Iluvien (Drug) $153.93
  • Monaco (Device) $149.53
  • EYLEA HD (Biological) $128.28
  • ForeseeHome (Device) $127.28
  • Tecnis IOL (Medical Supply) $109.20
  • Constellation (Device) $80.12
  • Spectralis (Device) $79.88
  • Cimerli (Biological) $27.36
  • Susvimo (Drug) $24.46
  • ACTHAR (Biological) $17.82
  • STELLARIS PC (Device) $17.45
  • Lucentis (Biological) $14.65
  • DEXYCU (Drug) $14.41

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Independence